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data. We compared the performance of our method with 
the methods of Berntson and Clifford on the same data. 
We identified 257,458 R-peak detections, of which 235,644 
(91.5%) were true detections and 21,814 (8.5%) arose from 
artifacts. Our method showed superior performance for 
detecting artifacts with sensitivity 100%, specificity 99%, 
precision 99%, positive likelihood ratio of 100 and negative 
likelihood ratio <0.001 compared to Berntson’s and Clif-
ford’s method with a sensitivity, specificity, precision and 
positive and negative likelihood ratio of 99%, 78%, 82%, 
4.5, 0.013 for Berntson’s method and 55%, 98%, 96%, 27.5, 
0.460 for Clifford’s method, respectively. A novel algo-
rithm using a patient-independent threshold derived from 
the distribution of adRRI values in ICU ECG data identi-
fies artifacts accurately, and outperforms two other methods 
in common use. Furthermore, the threshold was calculated 
based on real data from critically ill patients and the algo-
rithm is easy to implement.
Keywords Heart rate variability · ECG artifacts · 
Intensive care · ICU
1 Introduction
Heart rate variability (HRV) [1–5] monitoring is increas-
ingly used in the intensive care unit (ICU) as a continu-
ous noninvasive index with potential to serve as an early 
warning signal of worsening illness. Recent successful 
applications include detection of sepsis in neonates and 
adults [6–9], tracking the depth of sedation in patients on 
mechanical ventilation [10], and detection of delayed cer-
ebral ischemia following subarachnoid hemorrhage (SAH) 
[11, 12].
Abstract We developed a simple and fully automated 
method for detecting artifacts in the R-R interval (RRI) 
time series of the ECG that is tailored to the intensive care 
unit (ICU) setting. From ECG recordings of 50 adult ICU-
subjects we selected 60 epochs with valid R-peak detec-
tions and 60 epochs containing artifacts leading to missed 
or false positive R-peak detections. Next, we calculated the 
absolute value of the difference between two adjacent RRIs 
(adRRI), and obtained the empirical probability distribu-
tions of adRRI values for valid R-peaks and artifacts. From 
these, we calculated an optimal threshold for separating 
adRRI values arising from artifact versus non-artefactual 
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Nevertheless, the presence of signal artifacts poses a 
challenge to routine HRV monitoring in the ICU environ-
ment. HRV measures are calculated from the R-R interval 
(RRI) [13] time series derived from the electrocardio-
gram (ECG), which requires accurate localization of QRS 
complexes. Failure to identify and correct for artifacts 
can substantially degrade the value of HRV measures.
[14–17].
Practical ICU applications of HRV monitoring require 
fully automated ECG artifact detection methods. The 
method in widest use was proposed by Berntson et  al. 
[18], and is based on the distribution of differences in 
RRIs. Because RRI differences arising from artifacts are 
typically large compared to valid RRIs, large RRI differ-
ences serve to identify potential artifacts. However, this 
algorithm relies on statistics derived from the RRI time 
series of an individual’s ECG, and is thus patient depend-
ent, i.e. will behave differently in different patients, par-
ticularly in high-artifact settings. Moreover, the method 
was validated on data from chimpanzees and young 
healthy volunteers with simulated artifacts. Thus it is 
unclear how effectively this algorithm may perform in an 
actual ICU setting. Clifford et  al. [14] developed a sim-
pler, patient-independent automatic artifact identifica-
tion algorithm based on variation of adjacent RRIs. Their 
method exhibited a moderately good accuracy of 67%, 
but also was not validated in critically ill patients or in 
the ICU setting.
To overcome these limitations, we developed a simple 
and fully automated method for detecting artifacts in the 
RRI time series that is tailored to ICU data. Our intended 
application is monitoring HRV in patients with subarach-
noid hemorrhage.[11, 12] Thus, we optimized the algo-
rithm parameters and validated its performance on a large 
set of ICU ECG recordings from a diverse group of criti-
cally ill patients with SAH. We present our method and 
compare the performance with the Berntson and Clifford 
methods on the same data.
2  Methods
2.1  Patient selection
Archived ECG recordings were retrieved for analysis from 
patients admitted to the Massachusetts General Hospi-
tal (MGH) Neurosciences Intensive Care Unit (NICU). 
We selected convenience samples of 50 subjects admitted 
between 2012 and 2015 for whom archived ECG record-
ings were available. This study was carried out under a 
protocol approved by the local institutional review board 
(IRB). Patient consent was not required.
2.2  Data acquisition
ECGs were recorded at 240  Hz. Training data for algo-
rithm development was established as follows. From each 
patient’s ECG, 60  s-long epochs with only valid R-peak 
detections and 60  s-long epochs containing artifacts were 
selected visually as described below by one of the authors 
with clinical expertise (MBW). Putative R-peaks were 
automatically detected within these 60 s segments using the 
Pan-Tompkins algorithm [19]. A valid epoch was defined 
as one in which every detected R-peak corresponded to a 
real R-peak, and in which no R-peak was missed. All other 
epochs were defined as “artifact” epochs. Note that artifact 
epochs typically contained at least some valid R-peaks in 
addition to missed peaks and false detections. All analysis 
was performed in Matlab (R2014b, Mathworks, Natick, 
MA, USA).
2.3  RRI and adRRI
ECG artifacts cause errors in the RRI interval time series 
either via missed R-peaks or false detected R-peaks. Both 
of these error types result in larger-than-typical absolute 
differences between adjacent RRIs. Therefore, large jumps 
in the difference between consecutive RRI values have an 
increased probability of being due to an artifact compared 
with differences arising from variation in valid RRIs. Our 
approach attempts to identify a single optimal threshold 
value for the absolute difference of the RRI by which to dis-
criminate valid R-peaks from artifacts. We postulated that a 
single optimal threshold can be obtained that can satisfac-
torily detect artifacts across ECGs from different patients.
As candidate features for artifact detection, we exam-
ined both the RRI and the absolute value of the difference 
between two adjacent RRIs: the adRRI. The RRI is defined 
as:
with Rn as the nth detected R-peak. The RRI is the time 
between two adjacent detected R-peaks: Rn and Rn+1 (for 
which R is a detected R-peak by the Pan-Tompkins algo-
rithm [19]). The adRRI is defined as:
and is the absolute value between two adjacent RRIs: RRIn 
and RRIn+1. Because values of RRIs and adRRIs span a 
wide range, for the purposes of plotting distributions of 
these values hereafter in plots we will work with their loga-
rithms to allow better visualization.
As noted above, there are two possible types of arti-
facts: either a spurious R-peak is falsely detected, or a real 
R-peak is missed. In general, a spuriously detected peak 
results in a shorter RRI, while a missed peak results in a 
(1)RRIn = Rn+1 − Rn
(2)adRRIn = ||RRIn − RRIn+1||
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longer RRI. This requires two thresholds for RRI artifact 
detection: a low RRI threshold for spurious peaks and a 
high RRI threshold for missed peaks. For the adRRI, both 
spurious and missed peaks result in an increased absolute 
difference between RRIs compared with those arising from 
valid R-peaks. For this reason, only a single threshold is 
required for artifact detection with the adRRI. This is illus-
trated in Fig. 1.
2.4  Definition of true labels
We developed two different versions of our algorithm (two 
different threshold values), based on (1) coarse-grained 
labeling of entire epochs as either artefactual versus valid, 
and (2) fine-grained labeling of individuals R-peaks as 
being artefactual versus valid.
2.4.1  Labeling of epochs
To allow detection of epochs containing artifacts, one 
of the authors (MBW) visually inspected all epochs and 
labeled each as “valid”, containing no artefactual R-peak 
detections; or “artifact”, containing one or more artefactual 
R-peak detection. Note that “artifact” epochs may contain a 
mixture of correct and spurious R-peak detections
2.4.2  Labeling of individual R‑peaks
We labeled individual peaks in artifact epochs by a three-
step series of manual and computational methods guided 
by direct visual inspection, as follows. First, for each case 
we calculated individualized thresholds, in two ways: to 
maximize the accuracy in discriminating between either the 
log-RRI or the log-adRRI values from the manually labeled 
“valid” and “artifact” within that ECG (see Fig. 2). Second, 
using these thresholds (two for the log-RRIs, one for the 
adRRI), we performed an initial categorization of individ-
ual R-peaks within artifact intervals as true vs artefactual 
detections. Finally, we added the false flag alarm (FA) of 
Berntson et al. [18] to further improve the accuracy of the 
peak detections (see supplement 1 for further details).
Empirically, we found that the three-step procedure 
described above generally gave better performance when 
relying on log-adRRI than on RRI. Accordingly, the final 
labels for individual artifact peaks were defined using the 
above multi-step procedure using the log-adRRI labels.
Fig. 1  Overview of the RRI 
and adRRI derived from 
R-peak detection of the ECG. 
In a the ECG is shown where 
the blue signal represents a 
series of completely valid peak 
detections and the red signal 
represents a series of peak 
detections containing two errors 
(resulting from application of 
the Pan-Tompkins algorithm 
[19]). The two errors include 
a spurious peak (Rx) and a 
missed peak (R6). In b the RRI 





. The valid 
peak detections (blue) corre-
spond to an essentially constant 
sequence of RRIs. For the red 
detections, the spurious R-peak 
Rx results in two decreased RRIs 
(red B2, B3) and a missed peak 
R6 results in an increased RRI 
value (red B6). In c the adRRI 
is shown as An, calculated as 
A
n
= ||Bn − Bn+1
|
|
. The valid 
peak detection (blue) has a 
constant value around zero, but 
for the red signal both a spuri-
ous detected (A1, A3) peak and a 
missed R-peak (A6, A7) result in 
an increased adRRI, signaling 
the presence of an artifact
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2.5  Artifact identification methods
We compared the performance of three methods on our 
ICU ECG data, hereafter designated as (A), our new 
method: the ‘ADARRI’ (Absolute value of the Differ-
ence between Adjacent RR Intervals) method; (B), Bern-
tson’s method, and (C) Clifford’s method. Whereas both 
method A and B use the absolute difference between 
two RRIs to detect artifacts, method C applies the rela-
tive difference between two adjacent RRIs. We hypoth-
esized that combining these methods might improve 
accuracy for artifact identification. Hence, we also eval-
uated sequential application of a combination of meth-
ods A and C (AC), and methods B and C (BC). Finally, 
we evaluated whether applying the FA detection routine 
of Bertnson et  al. [18] (hereafter referred to as “FA-
edit”) was able to improve the performance of method 
A. The FA-edit routine attempts to refine or “edit” the 
initial artifact detections by identifying detections that 
are likely to be incorrect (false positives). For combined 
methods AC and BC, a detected R-peak was labeled as 
an artifact if method 1 OR/AND method 2 identifies it 
as artifact. This resulted in six different artifact detec-
tion methods: (1) A; (2) A + FA-edit; (3) B; (4) C; (5) 
AC; (6) BC. The working mechanism of the ADARRI 
method (A), Berntson’s method (B) and Clifford’s 
method (C) are explained next.
2.5.1  ADARRI method (A)
 Our artifact identification algorithm is based on a single 
threshold value, derived from the log-adRRI distributions 
of artifacts and valid data pooled from all 50 patients. 
This threshold was calculated within the range of [1–500] 
(with step size = 1) as the threshold with the highest 
accuracy (accuracy = (true positive + true negative)/
total detections) for artifact detection, based on balanced 
sets of epochs with valid R-peaks and artifacts from all 
50 subjects (see statistical analysis below regarding data 
balancing).
2.5.2  Berntson method (B)
Berntson’s method is also based on differences between 
the distributions of valid and abnormal R-peak detections. 
The threshold in method B is derived from the interquar-
tile range and the median of the probability distribution of 
adRRI values. Berntson’s method includes also an algo-
rithm to identify and remove false alarms (FA, i.e. falsely-
detected artifacts), using the same threshold for artifact 
detection (see supplement 1 for more detail). For method B 
patient individual thresholds were calculated based on the 
interquartile range and the median of the probability of all 
the adRRI values for the subject.
2.5.3  Clifford method (C) 
For the Clifford method, an R-peak was labeled as an arti-
fact if the RRI differs by more than 20% from the previous 
RRI.
We evaluated the overall performance on all 50 patients 
for all six methods described above: A, A + FA-edit, B, C, 
AC, BC based on balanced samples of valid R-peaks and 
artifacts from all 50 subjects. Furthermore, we evaluated 
1 2 3 4 5 6 7 8 9






















Fig. 2  Kernel probability density function estimation of the adRRI. 
The log of the distribution of the individual true peaks (blue) and 
artifact peaks (red) of the adRRI estimations for all subjects. The 
adRRI of the true peaks are much lower than the adRRI of artifact 
peaks, although there is a small overlap
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the performance of methods A, B and C for all 50 patients 
individually. These methods are tested in two ways: (1) for 
the detection of “artifact containing epochs”, which labels 
the whole epoch as “artifact” if an artifact was detected and 
(2) “artefactual R-peak”, which labeled each individual 
R‑peaks as “valid” or “artifact”. These are further denoted 
as epoch evaluation and individual R‑peak evaluation, 
respectively.
2.6  Statistical analysis
For each method we calculated the sensitivity (SE), speci-
ficity (SP), positive predictive value (PPV) and both the 
positive and negative likelihood ratio (LR+ and LR−) for 
detecting artifacts and are defined as:
Performance measures were plotted in receiver operating 
curves (ROC) and precision-recall (PR) curves. For method 
A and A + FA-edit the area under the curve (AUC) was cal-
culated. For individual patient performance, the SE, SP and 
PPV, LR+ and LR− were calculated as medians (interquar-
tile range) over all 50 subjects.
To deal with the imbalanced number of valid and arte-







randomly without replacement from the larger group to 
yield groups of equal size. All performance statistics were 
then calculated on the balanced dataset. This balancing pro-
cedure was repeated 20 times and the average values were 
used as the final reported performance measures.
3  Results
3.1  Patient selection
Five “artifact” epochs were excluded due to a complete 
absence of data within the epoch (hence no R-peak detec-
tions), yielding 2995 “valid” and 3000 “artifact” epochs. 
Among 257,738 total R-peak detections, 235,644 (91.5%) 
were true detections and 22,094 (8.5%) were due to arti-
facts. The mean heart rate for valid epochs was 79 ± 16 bpm 
and for “artifact” epochs 78 ± 23 bpm.
3.2  Overall performance
Overall performance results for the six different methods 
(A, A + FA-edit, B, C, AC, BC) are shown in ROC and PR 
plots in Figs.  3 and 4 for epochs and individual R-peaks, 
respectively. The optimal overall threshold for method A 
was θ = 276 ms for detecting artifact-containing epochs and 
θ = 85  ms for detecting individual abnormal R-peaks; the 
mean patient-optimized threshold for method B was θ = 18 
(10–40) ms.
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θ = 276 ms
Fig. 3  Overall performance of epochs. A = ADARRI method, 
A + FA-edit = Method A with FA-edit, B = Berntson method, 
C = Clifford method, AC = combination of A and C and BC = com-
bination of B and C. ӿ = Optimized threshold value for method 
A. a ROC curves of overall performance of epochs. Method A and 
A + FA-edit have the highest accuracy with SE = 96% and SP = 83%. 
b The PR curves of overall performance of epochs. Method A 
and A + FA-edit show the best performance with SE = 96% and 
PPV = 85%
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Inspecting the ROC and PR curve for epoch evaluation 
(Fig. 3), the curves for method A, A + FA-edit and AC span 
a wide range of possible performance set points depend-
ing on the chosen threshold value. Methods B, C and BC 
exhibit only a single operating point, because they each use 
a fixed threshold value. Method A and A + FA-edit show 
identical performances (AUC = 95.26). Method AC over-
laps partially with method A and A + FA-edit, but cannot 
achieve points with SP higher than 58%. Method A (as 
well as A + FA-edit) performs best since its ROC curve is 
above all the other methods. At the threshold value that 
provides maximum accuracy (θ = 276  ms), method A 
obtains SE = 96%, SP = 83%, PPV = 85%, LR + = 5.9 and 
LR−= 0.056.
Inspecting the ROC and PR curve for individual 
R‑peak evaluation (Fig.  4), again the curves for method 
A, A + FA-edit and AC exhibit a wide range of pos-
sible performance values as a function of the chosen 
threshold value. Also here, method B, C and BC use a 
fixed threshold which results in single operating points. 
Method A (AUC = 99.07%) performs negligibly bet-
ter than A + FA-edit (AUC = 99.06%). Method AC par-
tially overlaps with method A and A + FA-edit, but can-
not achieve SP values below 97%. Method A performs 
best overall. At the threshold value that provides maxi-
mum accuracy (θ = 85 ms) method A obtains SE = 99%, 
SP = 95%, PPV = 95%, LR + = 21.9 and LR− =  0.08. The 
overall performance statistics for all methods are shown 
in Table 1.
3.3  Individual patient performance
Inspecting performance of the methods optimized for indi-
vidual patient performance, in the case of epoch evalua‑
tion, method A performs best with SE = 100%, SP = 75%, 
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Fig. 4  Overall performance of individual R-peaks. A = ADARRI 
method, A + FA-edit = Method A with FA-edit, B = Berntson method, 
C = Clifford method, AC = combination of A and C and BC = com-
bination of B and C. ӿ = Optimized threshold value for method A. 
a The ROC curves of overall performance of individual R-peaks. 
Method A, A + FA-edit and AC have the highest accuracy with 
SE = 99% and SP = 95–92%. b The PR curves of overall performance 
of individual R-peaks. Method A, A + FA-edit and AC have the best 
performance with SE = 99% and PPV = 95–93%
Table 1  Performance of all methods based on all subjects
Sensitivity (SE), specificity (SP), precision (PPV) and positive and 
negative likelood ratio (LR+, LR−), displayed as percentages of the 
total RRIs of all subjects. Method A uses a threshold of θ = 276 ms 
for epoch evaluation and θ = 85 ms for individual R-peak evaluation. 
Method B uses patient-optimized thresholds. Method AC shows the 
same results as method C for epochs and method A for individual 
R-peaks. Method A + FA-edit is not displayed because it has the same 
performances as method A
SE (%) SP (%) PPV (%) LR+ LR−
Epoch evaluation
 Method A 96 83 85 5,6 0,048
 Method B 100 2 50 1,0 0,000
 Method C 98 58 69 2,3 0,034
 Method AC 98 58 69 2,3 0,034
 Method BC 100 12 53 1,1 0,000
Individual R-peak evaluation
 Method A 99 95 95 19,8 0,011
 Method B 100 74 79 3,8 0,000
 Method C 56 97 95 18,7 0,454
 Method AC 99 92 93 12,4 0,011
 Method BC 95 79 82 4,5 0,063
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PPV = 80%, LR + = 4, LR−  =  0. Method B shows also a 
high SE of 100% and low LR− = 0, but has low SP (2%), 
PPV (50%), LR + = 1. Method C performs moderately well 
with a SE = 90%, SP = 60% PPV = 68%, LR + = 2.3 and 
LR−  = 0.167.
For individual R‑peak evaluation, method A, opti-
mized for best performance across aggregated patient data, 
achieves excellent performance (SE = 100%, SP = 99%, 
PPV = 99%, LR + = 100, LR−  =  0); this near-perfect per-
formance is expected due to way the labels were defined 
(see Sect. “methods”) Using individually-optimized 
thresholds, method B performs with a high SE of 99% and 
LR− of 0.013, but with a moderate SP of 75%, PPV 82% 
and LR+ of 4.5. Method C performs with high SP of 98%, 
PPV 96% and LR+ of 27.5, but has a low SE of 55% and 
LR− of 0.46. The results of method A, B and C in order to 
optimize performance in individual patient ECG recordings 
are showed in Table 2.
4  Discussion
We present the novel ADARRI algorithm to detect arti-
facts in RRI time series derived from ECG recordings 
in ICU patients. The method exhibits high accuracy for 
evaluation of epochs with a performance of SE = 100%, 
SP = 75%, PPV = 80%, LR + = 4, LR− = 0 and even higher 
performance for evaluation of individual R-peaks, with an 
overall performance of SE = 100%, SP = 99%, PPV = 99%, 
LR + = 100 and LR−  =  0. On our data, the new method 
outperforms two other commonly used methods.
Berntson et al’s [18] method achieved SE of 100% and 
SP of 99% on healthy subjects with added simulated arti-
facts. In our ICU population, we found a SE of 99% and 
SP of 78% for individual peaks when using the individually 
optimized thresholds of Berntson. On the same ICU data, 
our method performed better with a SE of 100% and SP of 
99%, suggesting that our method with a single threshold 
identifies artifacts more reliably than Berntson’s method 
with individualized threshold values.
Furthermore, the threshold required in Berntson’s 
method depend on estimates of the interquartile range and 
the median of the probability distribution of adRRI values 
for data from each patient’s data, and thus implicitly relies 
on the majority of the data being free of artifacts to ensure 
consistent results. This assumption may not hold in the ICU 
setting where artifacts are abundant. Kaufmann et al. [20] 
developed an HRV analysis program and implemented the 
Berntson’s algorithm to detect artifacts in the RRI time 
series [18]. They argued that specific threshold settings 
are not applicable across patients because of differences 
in mean RRIs between patients. However, we found that 
our method using a globally optimized threshold achieved 
a better sensitivity, specificity, positive predictive value 
and positive and negative likelihood ratios than Berntson’s 
method with individualized thresholds.
Clifford et  al. [14] investigated the relation of ectopic 
beats and artifacts with the time of the day, heart rate and 
state changes. Their ECG data also came from healthy 
subjects and resulted in a sensitivity of 67%. Using Clif-
ford’s method on our data, we found a sensitivity of 56% 
with corresponding specificity and positive prediction 
values >95% for R-peak evaluation. In contrast, our new 
method obtained a sensitivity of 99% and SP and PPV both 
of 99%. These results suggest that Clifford’s method does 
not have sufficiently high accuracy in critically ill patients 
as we found using our method.
Inspection of the ROC and PR curves for individual 
R-peaks shows that a combination of Berntson’s and Clif-
ford’s methods improves the performance over method B 
or C alone. However, Berntson’s method as well as Clif-
ford’s method combined with our ADARRI method do 
not obtain better performance than our method alone. 
Table 2  Performance of 
method A, B and C for 
individual subjects
The performance of individual subject artifact classification according to method A (an overall optimized 
threshold), method B (patient-optimized threshold value) and method C, which does not use a threshold. 
The SE, SP, PPV, LR+ and LR− are displayed as medians and interquartile ranges (25–75%) of all 50 sub-
jects
SE (%) SP (%) PPV (%) LR+ LR−
Epoch evaluation
 Method A 100 (100–100) 75 (41–90) 80 (63–91) 4 (1.8–10) 0 (0–0)
 Method B 100 (100–100) 2 (0–8) 50 (50–52) 1.0 (1.0–1.1) 0 (0–0)
 Method C 90 (85–92) 60 (35–78) 68 (58–80) 2.3 (1.3–4.6) 0.167 (0.429−0.103)
Individual R-peak evaluation
 Method A 100 (100–100) 99 (96–100) 99 (96–100) 100 (25–inf) 0 (0–0)
 Method B 99 (99–100) 78 (72–92) 82 (78–93) 4.5 (3.5–14.3) 0.013 (0.014–0)
 Method C 55 (52–59) 98 (96–99) 96 (93–97) 27.5 (13–59) 0.460 (0.5–0.414)
 J Clin Monit Comput
1 3
Furthermore, FA-edit does not improve the performance 
of our method.
The primary strength of our study is that we used con-
tinuous ECG recordings of critically ill patients instead of 
healthy subjects. In addition, the large number of epochs 
and individual peaks we used argues for generalizability of 
our results. Finally, we conducted a thorough comparison 
with two existing methods in common use, thus providing 
evidence for the advantages of the new method presented 
herein.
It was not possible to visually inspect and confirm all 
257,458 R-peaks to confirm that the correctness of the 
labels of “true” and “artifact” assigned by our three-step 
data labeling method. Rather, while we manually iden-
tified epochs containing artifacts, the subsequent steps 
used to label individual peaks within each epoch as valid 
versus artefactual were automated. It is thus possible that 
an expert might disagree with some of the resulting label 
assignments. However, based on the design of our method 
and visual inspection of selected samples, we are confident 
that the fraction of mislabeled peaks is negligibly small.
An important limitation of our work is that we do not 
investigate the cause of abnormal R peak detections. While 
we have described our task as detecting “artifacts”, in some 
cases beats that are statistical outliers may have important 
physiological implications. Examples include long pauses 
or “dropped beats”, and episodes of extreme tachycardia 
(e.g. atrial flutter or ventricular tachycardia). An important 
future direction for our work is thus to explore ways to dis-
criminate between abnormal beats that represent true arti-
fact (noise) vs those which represent clinically significant 
events. Nevertheless, it is still useful to identify and remove 
highly abnormal beats regardless of their source for appli-
cations that depend on measures of HRV. This is because 
HRV applications are primarily concerned with extracting 
information from the ECG about the state of the autonomic 
nervous system, whereas ectopic beats arise from processes 
within the heart itself [15].
A second limitation is that, similar to other work, our 
approach relies on visual analysis by a clinical expert to 
define the gold standard, i.e. which detected ECG beats 
are artefactual. While we feel that this approach is justified 
(the majority of ECG artifacts are obvious on visual inspec-
tion), an even more rigorous approach would be to evaluate 
the algorithm against an artifact-free dataset—a “platinum 
standard”. This might be possible in future work, for exam-
ple, by making ECG recordings in a cohort of ICU patients 
using 12-lead ECGs or invasive recordings (e.g. in patients 
with pacemakers), and using advanced methods or visual 
review by multiple cardiologists to label all beats as true 
versus artefactual.
HRV monitoring is a continuous, noninvasive tool 
increasingly used in the ICU in order to serve as a warning 
system and early detection application for worsening illness 
in critically ill patients [1]−[5] Recent applications of HRV 
monitoring include early diagnosis of sepsis in neonates 
[6, 8, 9] and adults [7], monitoring the depth of sedation in 
mechanically ventilated ICU patients [10] and preclinical 
detection of major adverse cardiopulmonary events [12] as 
well as secondary complications [11] after SAH. As these 
applications become crucial in the ICU setting, artifact-free 
HRV monitoring will be imperative. Furthermore, correct 
localization of the QRS complexes in order to obtain the 
HRV is a challenging task in the presence of noise and arti-
facts in the ICU environment [13]. Failure to identify and 
correct for artifacts can substantially degrade the value of 
HRV measures.[14]–[17] Our method provides a tool for 
substantially improving the quality of HRV analysis by 
accurately identifying artefactual R-peak detections.
5  Conclusion
In this study, a novel “ADARRI” algorithm based on the 
absolute value of differences between adjacent RR Intervals 
(adRRI) was introduced to identify artefactual R-peaks in 
the ECG for HRV analysis. This method employs a single, 
patient-independent threshold derived from the differences 
between the adRRI distributions for valid vs artefactual 
detections. Compared to two other methods in common 
use, and variations on these methods, ADARRI identifies 
artifacts more accurately. Furthermore, our algorithm was 
derived from real data obtained from ECG recordings of 
critically ill patients in a noisy hospital environment, the 
ICU. This simple algorithm provides a useful preprocess-
ing step for analyses of HRV in the ICU setting.
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